Director Mauricio Ramos bought 9,929 shares of CHTR at $140.93, doubling holdings to 19,309 shares amid 67.7% pullback from 52-week high.
Ramos Mauricio, a Director, purchased 9,929 shares (9.9K shares) at $140.93 on 2026-05-15, increasing his holdings by 105.9% from 9,380 to 19,309 shares—a material increase in personal exposure totaling $1,399,307.87 ($1.4M). The purchase occurred after the stock declined 67.7% from its 52-week high of $437.06 and dropped 40.3% over the prior 30 days, representing a significant repricing environment. CHTR trades at a P/E of 7.75 on $1.2B net income ($13.6B quarterly revenue), and the company has contracted -0.6% year-over-year in annual revenue, creating a backdrop of operational headwinds. The director's commitment of substantial capital to exactly double his share count at depressed valuation levels warrants investor attention as a data point in assessing conviction among the company's leadership.